Digital tools key to immuno-oncology’s future: reportIf ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows Share XDigital tools key to immuno-oncology’s future: reporthttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/digital-tools-key-to-immuno-oncology-future-report/
Oncology and a year of COVID: lessons for the futureCOVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up Share XOncology and a year of COVID: lessons for the futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/
How hybrid virtual engagement is accelerating oncology communicationCOVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement Share XHow hybrid virtual engagement is accelerating oncology communicationhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/how-hybrid-virtual-engagement-is-accelerating-oncology-communication/
Enabling healthcare’s digital futureDebiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides Share XEnabling healthcare’s digital futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/enabling-healthcares-digital-future-debiopharm/
What HCPs think about health equity in cancer careAfter more than a year of COVID-19 dominating health conversations, HCPs have been engaging in dialogue about continually Share XWhat HCPs think about health equity in cancer carehttps://pharmaphorum.com/views-and-analysis/what-hcps-think-about-health-equity-in-cancer-care/
Digital health developments: a new investment era for start-upsHealthware Labs’ Kristin Milburn explores how digital health start-ups can harness the huge potential for the sector in Share XDigital health developments: a new investment era for start-upshttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/digital-health-developments-a-new-investment-era-for-start-ups/
Health Innovators – Jo Brewer, AdaptimmuneIn this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic Share XHealth Innovators – Jo Brewer, Adaptimmunehttps://pharmaphorum.com/video/health-innovators-jo-brewer-adaptimmune/
Why pharma shouldn’t forget about sites in a post-COVID worldThe pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we Share XWhy pharma shouldn’t forget about sites in a post-COVID worldhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/
When biotech meets reality TV – Starton Therapeutics faces the Unicorn HuntersStarton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that Share XWhen biotech meets reality TV – Starton Therapeutics faces the Unicorn Huntershttps://pharmaphorum.com/views-and-analysis/when-biotech-meets-reality-tv/
